NEWS
Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims
New Patent is Added to the Company's Portfolio of Formulations that Rapidly Reduce Blood Alcohol Content
JUPITER, Fla., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (NASDAQ:SHOT) ("Safety Shot" or "the Company"), a wellness company behind the world's first rapid alcohol reducer that lowers blood alcohol content ("BAC") by supporting its metabolism in as little as 30 minutes, has announced the Notice of Allowance of for a U.S. patent that covers its newest clinically-backed formula.
JUPITER, Fla., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (NASDAQ:SHOT) ("Safety Shot" or "the Company"), a wellness company behind the world's first rapid alcohol reducer that lowers blood alcohol content ("BAC") by supporting its metabolism in as little as 30 minutes, has announced the Notice of Allowance of for a U.S. patent that covers its newest clinically-backed formula.
"This latest patent marks a significant milestone in Safety Shot's quest to lead a brand-new category that the Company has created to solve alcohol related problems," stated Safety Shot COO and co-owner of the patent, David Sandler.
The Company's family of patents aims to corroborate Safety Shot's competitive advantage in the market which includes being faster at removing alcohol, improving cognitive ability, and reducing impairment by supporting the metabolism of alcohol. The latest patent continues to advance an exciting new category of functionality.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
2411Followers
107Following
26KVisitors
Follow